Vaidya Sane
NSE: MADHAVBAUG · Medical Equipment & Supplies
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Vaidya Sane's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Vaidya Sane Ayurved Laboratories Ltd, operating under the brand Madhavbaug, is a healthcare provider specialising in non-invasive, Ayurveda-based treatments for chronic conditions such as heart disease, diabetes, and hypertension. The company integrates traditional Ayurvedic practices with modern diagnostic technology and maintains in-house manufacturing capabilities for its proprietary medicines and nutritional products.
Business Model
The company generates revenue through a hybrid model involving the operation of a network of cardiac care clinics and hospitals alongside the retail sale of Ayurvedic medicines and health supplements.
Growth Outlook
Growth is driven by the increasing demand for non-invasive cardiac care and the expansion of their integrated clinic-hospital network across India.
Key Risks
- Regulatory Risk. The company is subject to stringent and evolving regulations governing the Ayurvedic medicine and healthcare sectors in India.
- Clinical Efficacy Perception. The business model relies on public acceptance of Ayurveda-based treatments for critical chronic conditions like heart disease.
- Operational Scalability. Maintaining consistent quality of care and service standards across a growing network of clinics and hospitals presents significant operational challenges.
- Competition. The company faces intense competition from both conventional allopathic cardiac care providers and other alternative medicine practitioners.
Start your research today
Unlock AI insights, financials, peers and live data on Vaidya Sane and 5,000+ companies — free.
Peers · Medical Equipment & Supplies
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Vaidya SaneMADHAVBAUG | ₹180 Cr | — | — | — | 10.4% | — | — | -38.1% |
Tarsons ProductsTARSONS | ₹1,785 Cr | 157.61 | 14.68 | 10.6% | 33.1% | 1.8% | 4.5% | +6.6% |
Laxmi DentalLAXMIDENTL | ₹1,072 Cr | 34.25 | 19.35 | — | 19.2% | 13.7% | 13.3% | -40.8% |
Hemant Surgical Industries LimitedHSIL | ₹894 Cr | — | — | — | 10.0% | — | — | +91.5% |
Vasa Denticity LimitedDENTALKART | ₹718 Cr | — | — | — | 4.2% | — | — | -24.1% |
Prevest DenproPREVEST | ₹461 Cr | — | — | — | 36.0% | — | — | -31.1% |
As of Mar 2026
Financials
Vaidya Sane
NSE: MADHAVBAUG · Medical Equipment & Supplies
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Vaidya Sane's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Vaidya Sane Ayurved Laboratories Ltd, operating under the brand Madhavbaug, is a healthcare provider specialising in non-invasive, Ayurveda-based treatments for chronic conditions such as heart disease, diabetes, and hypertension. The company integrates traditional Ayurvedic practices with modern diagnostic technology and maintains in-house manufacturing capabilities for its proprietary medicines and nutritional products.
Business Model
The company generates revenue through a hybrid model involving the operation of a network of cardiac care clinics and hospitals alongside the retail sale of Ayurvedic medicines and health supplements.
Growth Outlook
Growth is driven by the increasing demand for non-invasive cardiac care and the expansion of their integrated clinic-hospital network across India.
Key Risks
- Regulatory Risk. The company is subject to stringent and evolving regulations governing the Ayurvedic medicine and healthcare sectors in India.
- Clinical Efficacy Perception. The business model relies on public acceptance of Ayurveda-based treatments for critical chronic conditions like heart disease.
- Operational Scalability. Maintaining consistent quality of care and service standards across a growing network of clinics and hospitals presents significant operational challenges.
- Competition. The company faces intense competition from both conventional allopathic cardiac care providers and other alternative medicine practitioners.
Start your research today
Unlock AI insights, financials, peers and live data on Vaidya Sane and 5,000+ companies — free.
Peers · Medical Equipment & Supplies
As of Mar 2026